Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules with potential antitumor and antimicrobial properties. It serves as a building block in organic synthesis, enabling the introduction of morpholine-based moieties into larger structures to enhance solubility and binding affinity. Commonly employed in medicinal chemistry for structure-activity relationship studies due to its halogenated aromatic group, which allows for further functionalization via cross-coupling reactions. Also utilized in the preparation of kinase inhibitors and central nervous system agents where the morpholine ring contributes to improved pharmacokinetic profiles.